Get the Stockscreener App
44.55
1.82%
+0.70
Iradimed Corp stock is currently priced at $44.55, with a 24-hour trading volume of 31,062.
It has seen a +1.82% increased in the last 24 hours and a +5.53% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $43.29 pivot point. If it approaches the $44.81 resistance level, significant changes may occur.
Previous Close:
$43.85
Open:
$44.63
24h Volume:
31,062
Market Cap:
$559.69M
Revenue:
$65.56M
Net Income/Loss:
$17.19M
P/E Ratio:
38.41
EPS:
1.16
Net Cash Flow:
$5.46M
1W Performance:
+6.67%
1M Performance:
+5.53%
6M Performance:
-0.91%
1Y Performance:
+3.48%
1D Range:
$43.95
$45.23
52W Range:
$36.12
$51.04
Iradimed Corp Stock (IRMD) Company Profile
Name
Iradimed Corp
Sector
Industry
Phone
407-677-8022
Address
1025 Willa Springs Drive, Winter Springs
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-12-23 | Initiated | Lake Street | Buy |
| Oct-31-17 | Resumed | ROTH Capital | Buy |
| Oct-05-16 | Downgrade | ROTH Capital | Buy → Neutral |
| Nov-02-15 | Reiterated | ROTH Capital | Buy |
| Jul-30-15 | Reiterated | ROTH Capital | Buy |
| Jun-16-15 | Reiterated | ROTH Capital | Buy |
| Jan-12-15 | Reiterated | ROTH Capital | Buy |
| Dec-23-14 | Reiterated | ROTH Capital | Buy |
View All
Iradimed Corp Stock (IRMD) Latest News
IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
GlobeNewswire Inc.
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
GlobeNewswire Inc.
IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results
GlobeNewswire Inc.
IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th.
GlobeNewswire Inc.
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Acadia Healthcare (ACHC) Opens Facility to Serve California
Zacks Investment Research
Iradimed Corp Stock (IRMD) Financials Data
Iradimed Corp (IRMD) Revenue 2024
IRMD reported a revenue (TTM) of $65.56 million for the quarter ending December 31, 2023, a +23.00% rise year-over-year.
Iradimed Corp (IRMD) Net Income 2024
IRMD net income (TTM) was $17.19 million for the quarter ending December 31, 2023, a +34.02% increase year-over-year.
Iradimed Corp (IRMD) Cash Flow 2024
IRMD recorded a free cash flow (TTM) of $5.46 million for the quarter ending December 31, 2023, a -33.18% decrease year-over-year.
Iradimed Corp (IRMD) Earnings per Share 2024
IRMD earnings per share (TTM) was $1.36 for the quarter ending December 31, 2023, a +33.33% growth year-over-year.
About Iradimed Corp
IRadimed Corporation develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets under the MRidium name; and MRI compatible patient vital signs monitoring system under the IRadimed name. The company also offers IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its MRI compatible products through direct sales force and independent distributors. IRadimed Corporation was incorporated in 1992 and is headquartered in Winter Springs, Florida.
0.69%
Cap:
|
Volume (24h):